AI is analyzing your overall score…
Identifying your key strengths…
Evaluating your skill match against the job requirements…
Assessing your cultural and operational fit
Chief Product & Technology Officer | Building & Scaling Agentic AI Platforms & Products | B2B SaaS | Enterprise AI Agents
I’m a global CPTO, CTO, and CPO executive with 20+ years of experience building and scaling B2B SaaS, enterprise software, and AI businesses. My work centers on turning product and technology into business performance — revenue growth, profitability, operating leverage, customer impact, and long-term enterprise value. I’ve led organizations across Product, Design, Engineering, AI, Data, IT, and Cybersecurity in both private equity-backed and large enterprise environments. My experience spans building teams and platforms from scratch, scaling global organizations, and modernizing complex technology environments with stronger operating models, sharper commercial alignment, and more disciplined execution. As Chief Product & Technology Officer at VXI Global Solutions, a Bain Capital portfolio company, I lead the enterprise CX Agentic AI SaaS platform and broader technology modernization. I’ve built and scaled products across Agentic AI-led hiring, adaptive training, agent enablement, analytics, and automation, while also modernizing enterprise systems with agentic AI and strengthening cybersecurity posture. A core thread in my work is building data-driven organizations. I’ve led analytics, decision-support, and AI-driven operating systems that improve visibility, productivity, cost efficiency, and operating performance. I use agentic AI across both customer-facing products and internal workflows to drive execution quality, efficiency, and profitability. I’ve also built and reshaped teams for an AI-enabled software lifecycle, reworking how product, design, engineering, and AI operate together to improve speed, productivity, and commercial impact. I’m focused on how Agentic AI is changing the way software is built, deployed, and scaled in the enterprise.
Duke University - The Fuqua School of Business
Post Graduate Diploma, Health Sector Management
N/A – Present
M.S University
Bachelor of Engineering, Electronics and Telecommunication Engineering
N/A – Present
Mahatma Gandhi University, Kerala
Pre-Degree, Science and Math
N/A – Present
Duke University - The Fuqua School of Business
Master of Business Administration (MBA)
N/A – Present
Menlo Ventures
Menlo VC Fellow
January 1, 2024 – December 1, 2024
Palo Alto, California, United States · Hybrid
VXI Global Solutions
Chief Product & Technology Officer (CPTO - CTO & CPO) | A Bain Capital Portfolio Company
January 1, 2023 – Present
United States · Remote
OpenText
Global CTO & Head of Industry AI & Data Products | OpenText (via HPE Software/Micro Focus Merger)
January 1, 2017 – January 1, 2023
San Francisco Bay Area
Hewlett Packard Enterprise
Global CTO - Data & AI Products
January 1, 2016 – January 1, 2017
Hewlett Packard Enterprise
Head of Product and Solution Accelerators (Analytics & AI)
January 1, 2015 – January 1, 2016
HP
Global Head of Data Analytics & AI (Products, Solutions & GTM Strategy)
January 1, 2013 – January 1, 2015
Palo Alto, California
Thomson Reuters
Senior Manager - Corporate Strategy | Enterprise Software
January 1, 2011 – January 1, 2013
Dallas/Fort Worth Area · On-site
HP Autonomy
Sr. Product Manager | Forward Deployed Engineer | Enterprise Search AI | Acquired by HP for $11.7B
January 1, 2007 – January 1, 2011
Palo Alto, California, United States · On-site
GSK
Product Architect – Big Data & Artificial Intelligence Engineering
January 1, 2004 – January 1, 2007
Raleigh-Durham, North Carolina Area · On-site
Wipro Limited
Sr. Software Engineer/Co-Founder – Artificial Intelligence Practice
January 1, 2003 – January 1, 2007
Raleigh-Durham-Chapel Hill Area · Hybrid
Managing Life Cycle Of Branded Drugs – A Pricing Approach
January 1, 2009 – January 1, 2010
As part of my Duke Fuqua MBA coursework in W469: Strategy and Tactics of Pricing, I worked on a project exploring how pharmaceutical companies can maximize the profitability of blockbuster drugs over their patent life cycle. Using AstraZeneca’s Crestor and Pfizer’s Lipitor as case studies, we analyzed how branded drug manufacturers can respond to patent expiration and generic competition through efficacy-based, risk-sharing pricing models. The project examined how provisions under the Affordable Care Act (ACA) and Comparative Effectiveness Research (CER) could support outcome-based agreements between manufacturers and payers, creating a path to sustain value, improve market access, and optimize returns for proven therapies.
Dutch Disease - Symptoms, Mechanics & Recovery – A Case Study
January 1, 2009 – January 1, 2009
Skills: Economics · Market Research · Economic Policy
Global Media Ventures
January 1, 2009 – January 1, 2009
Business plan developed for ENTREPRENEURIAL STRATEGY FOR INNOVATION BASED VENTURES course
Cultural Fit Analysis
The candidate's career trajectory shows a consistent focus on innovation, particularly in AI and data, and a drive to build and transform businesses. Their experience across various large enterprises and their involvement in co-founding an AI practice at Wipro, along with their Menlo VC Fellowship, suggest an entrepreneurial mindset and adaptability. The diversity of projects, from pharmaceutical pricing to economic policy, indicates a broad intellectual curiosity. Their leadership roles in global teams and navigating mergers demonstrate resilience and a collaborative approach, aligning well with dynamic, high-growth environments. The target role of 'Product Lead' aligns perfectly with their extensive background in product management, strategy, and technical leadership.
Soft Skills & Operational Fit
The candidate demonstrates strong leadership, strategic thinking, and execution capabilities, evidenced by their roles in building and scaling product and AI organizations, driving significant revenue growth, and managing complex transformations. Their experience in integrating fragmented tech stacks and operating with agility under enterprise constraints suggests excellent problem-solving and operational management skills. The descriptions highlight collaboration with executive leadership, boards, and private equity, indicating strong stakeholder management and communication at the highest levels.